METFORMIN AND LACTIC ACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES – FROM PRIDE AND PREJUDICE TO SENSE AND SENSIBILITY

References

• Fantus IG. Metformin's contraindications: needed for now. CMAJ 2005; 173: 505–7.
   PubMed Web of Science ®Google Scholar
• Misbin RI. The phantom of Lactic acidosis due to metformin inpatients with diabetes. Diabetes Care 2004; 27: 1791–3.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Effect of inten-sive bLood-gLucose controL with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–65.
   PubMed Web of Science ®Google Scholar
• HoLstein A, StumvoLL M. Contraindications can damage your heaLth - is metformin a case in point? Diabetologia 2005; 48: 2454–9.
   PubMed Web of Science ®Google Scholar
• McCormack J, Johns K, TiLdesLey H. Metformin's contraindications shou Ed be contraindicated. CMAJ 2005; 173: 502–4.
   PubMed Web of Science ®Google Scholar
• EmsLie-Smith AM, BoyEe DI, Evans JM, Sullivan F, Morris AD. Contraindications to metformin therapy in patients with Type 2 diabetes - a popuLation-based study of adherence to prescrib-ing guidelines. Diabet Med 2001; 18:483–8.
   PubMed Web of Science ®Google Scholar
• HoLstein A, Egberts E-H. TraditionaL contraindications to the use of metformin - more harmfuL than beneficiaL?Dtsch Med Wschr 2006; 131: 105–10.
   Web of Science ®Google Scholar
• StacpooLe PW. Metformin and Lactic acidosis: gat by association (Ed itoria L). Diabetes Care 1998; 21: 1587–8.
   Web of Science ®Google Scholar
• Stades AM, Heikens JT, ErkeLens DW, Haeman F, Hoekstra JB. Metformin and Lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 2004; 255: 179–87.
   PubMed Web of Science ®Google Scholar
• Stades AME, Heikens JT, Haeman F, Hoekstra JBL. Metformin - current restrictions shouLd be alieviated. J Intern Med 2004; 256: 358.
   Web of Science ®Google Scholar
• Chang CT, Chen YC, Fang JT, Huang CC. Metformin-associated Lactic acidosis: case reports and Literature review.' Nephrol 2002; 15: 398–402.
   Web of Science ®Google Scholar
• Chu CK, Chang YT, Lee BJ, Hu SY, Hu WH, Yang DY. Metformin-associated Lactic acidosis and acute renaE faiLure in a type 2 diabetic patient. J Chin Med Assoc 2003; 66: 505–8.
   PubMedGoogle Scholar
• Orban JC, Giunti C, Levraut J, Grimaud D, Ichai C. Metformin-associated Lactic acidosis remains a serious complication of metformin therapy. Ann Fr Anesth Reanim 2003; 22: 461–5.
   PubMed Web of Science ®Google Scholar
• Moerer O, Barwing J, Neumann P. Lactic acidosis and acute abdomen from biguanide intoxication. Anaesthesist 2004; 53: 153–6.
   Google Scholar
• Becker C, LuginbühL A, PittE U, SchLienger R. Metformin-associ-ated Lactic acidosis in a patient with pre-existing risk factors. Schweiz Rundsch Med Prax 2005; 94: 1402–7.
   Google Scholar
• Brassoe R, ELkmann T, HempeL M, GravhoLt CH. FuLminant Lactic acidosis in two patients with Type 2 diabetes treated with metformin. Diabet Med 2005; 22: 1451–3.
   PubMed Web of Science ®Google Scholar
• DePaLo VA, MaiLer K, Yoburn D, Crausman RS. Lactic acidosis as-sociated with metformin use in treatment of type 2 diabetes meLLitus. Geriatrics 2005; 60: 36–41.
   PubMed Web of Science ®Google Scholar
• Fox GN. Metformin in type 2 diabetes. J Fam Pract 2004; 53: 900.
   PubMed Web of Science ®Google Scholar
• Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin--rapid reversaL and sur-vivaL despite high APACHE score. Diabet Med 2006; 23:432–5.
   PubMed Web of Science ®Google Scholar
• Friesecke S, AbeL P, Kraft M, Gerner A, Runge S. Combined renaE repLacement therapy for severe metformin-induced Lactic aci-dosis. Nephrol Dial Transplant 2006; 21: 2038–9.
   PubMed Web of Science ®Google Scholar
• Shenoy C. Metformin-associated Lactic acidosis precipitated by acute renaE fah re. Am J Med Sci 2006; 331: 55–7.
   PubMed Web of Science ®Google Scholar
• EL-Hennawy AS, Jacob S, Mahmood AK. Metformin-associated Lactic acidosis precipitated by diarrhea. Arn J Ther 2007; 14:403–5.
   Google Scholar
• Ortega Carnicer J, Ambrps Checa A, Martin Rodriguez C, Ruiz Lorenzo F, Portilla BoteLho M, Górnez Grande L. Metformin secondary to acute renaE insufficiency:a report of six cases. Med lntensiva 2007; 31: 521–5.
   Google Scholar
• ALivanis P, Giannikouris I, PaLiuras C, Arvanitis A, VoLanaki M, Zervos A. Metformin-associated Lactic acidosis treated with continuous renaE repLacement therapy. Clin Ther 2006; 28:396–400.
   PubMed Web of Science ®Google Scholar
• Berner B, HummeL KM, Strutz F, et al Metformin-associated Lactic acidosis with acute renaE faiLure in type 2 diabetes meL-Litus. Med Klin (Munich) 2002; 97: 99–103.
   Web of Science ®Google Scholar
• Pertek JP, VidaL S, Mariot J, GaLy-FLoc'h M, AzouLay E. Metformin-associated Lactic acidosis precipitated by acute renaE faiLure. Ann Fr Anasth Réanim 2003; 22:457–60.
   PubMed Web of Science ®Google Scholar
• Chan NN, Brain HP, Feher MD. Metformin-associated Lactic acidosis: a rare or very rare cLinicaL entity? DiabetMed 1999; 16: 273–81.
   Google Scholar
• LaEau J, Race J. Metformin and Lactic acidosis in diabetic humans. Diabetes Obes Metab 2000; 2:131–7.
   Web of Science ®Google Scholar
• Stang M, Wysowski DK, ButLer-Jones D. Incidence of Lactic aci-dosis in metformin users. Diabetes Care 1999; 22: 925–7.
   PubMed Web of Science ®Google Scholar
• Misbin RI, Green L, StadeL BV, Gueriguian JL, Gubbi A, FLeming GA. Lactic acidosis in patients with diabetes treated with met-formin. New EngIJ Med 1998; 338: 265–6.
   PubMed Web of Science ®Google Scholar
• SaLpeter SR, Greyber E, Pasternak G, SaLpeter E. Risk of fataE and non-fataL Lactic acidosis with metformin use in type 2 diabetes meLLitus. Cochrane Database Syst Rev 2006; 1 CD002967.
   Google Scholar
• Kamber N, Davis WA, Bruce DG, Davis TM. Metformin and Lactic acidosis in an Australian community setting: the FremantLe Diabetes Study. Med J Aust 2008; 188:446–9.
   PubMed Web of Science ®Google Scholar
• BaiLey CJ, Turner RC. Metformin. New Engl J Med 1996; 334: 574–9.
   PubMed Web of Science ®Google Scholar
• BaiLey CJ, HowLett HC. Defining the risk of Lactic acidosis. In: BaiLey CJ, CampbeLL IW, Chan JC (Eds). Metformin: the goLd standard. Chichester, UK: WiLey, 2007: 185–192.
   Google Scholar
• Runge S, MayerLe J, Warnke C, et al Metformin-associated Lactic acidosis in patients with renaE impairment soLeLy due to drug accu mu Lation? Diabetes Obes Metabolism 2008; 10:91–3.
   Web of Science ®Google Scholar
• Shaw JS, WiLmot RL, KiLpatrick ES. Establishing pragmatic esti-mated GFR threshoLds to guide metformin prescribing. Diabet Med 2007; 24:1160–3.
   PubMed Web of Science ®Google Scholar
• SeEby JV, Ettinger B, Swain BE, Brown JB. First 20 months' expe-rience with use of metformin for type 2 diabetes in a Large heaLth maintenance organization. Diabetes Care 1999 22: 38–44.
   Web of Science ®Google Scholar
• Gregorio F, Ambrosi F, FiLipponi P, Manfrini S, Testa I. Is met-formin safe enough for ageing type 2 diabetic patients? Diabe-tes Metab 1996; 22: 43–50.
   PubMed Web of Science ®Google Scholar
• HoLstein A, NahrwoLd D, Hinze S, Egberts E-H. Contra-indications to metformin are LargeLy disregarded. Diabet Med 1999; 16: 692–6.
   PubMed Web of Science ®Google Scholar
• Luft D, DeichseL G, Schmuffing RM, Stein N, Eggstein M. Defini-tion of clinicaRy reLevant Lactic acidosis in patients with internaL diseases. Am J Clin Pathol 1983; 80:484–9.
   PubMed Web of Science ®Google Scholar
• Davis TM, Jackson D, Davis WA, Bruce DG, Chubb P. The reLation-ship between metformin therapy and the fasting pLasma Lactate in type 2 diabetes: the FremantLe Diabetes Study. BrJ Clin Phar-macol 2001; 52: 137–44.
   PubMed Web of Science ®Google Scholar
• Franzetti I, Pack) D, Marco G, EmanueLa M, Elisabetta Z, Renato U. Possible synergistic effect of metformin and enaLapriL on the deveLopment of hyperka Liemic Lactic acidosis. Diabetes Res Clin Pract 1997; 38: 173–6.
   Web of Science ®Google Scholar
• Chan NN, FauveL NJ, Feher MD. Non-steroidaL anti-inflamma-tory drugs and metformin: a cause for concern? Lancet 1998; 352: 201.
   PubMed Web of Science ®Google Scholar
• Lim VCC, Sum CF, Chan ESY, Yeoh LY, Lee YM, Lim SC. Lactate LeveLs in Asian patients with type 2 diabetes meLLitus on met-formin and its association with dose of metformin and renaE function. Int J Clin Pract 2007; 61: 1829–33.
   Web of Science ®Google Scholar
• Kennedy L, Herman WH. Renal status among patients using metformin in a primary care setting. Diabetes Care 2005; 28: 922–4.
   PubMed Web of Science ®Google Scholar
• Gras V, Bouffandeau B, Montravers PH, Lalau JD. Effect of met-formin on survival rate in experimental sepsis. Diabetes Metab 2006; 32: 147–50.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Simpson SH, Toth EL, Majumdar SR. Reduced car-diovascular morbidity and mortality associated with met-formin use in subjects with Type 2 diabetes. Diabet Med 2005; 22: 497–502.
   PubMed Web of Science ®Google Scholar
• Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relation between sulfonylurea drugs and mortal-ity in type 2 diabetes mellitus:a population-based cohort study. CMAJ 2006; 174: 169–74.
   PubMed Web of Science ®Google Scholar